Terms: = Breast cancer AND PBX1, P40424, 5087
26 results:
1. Exosomes from LSD1 knockdown breast cancer cells activate osteoclastogenesis and inhibit osteoblastogenesis.
Liu Z; Zhang N; Xin B; Shi Y; Liang Z; Wan Y; Hu X
Int J Biol Macromol; 2023 Apr; 235():123792. PubMed ID: 36828097
[TBL] [Abstract] [Full Text] [Related]
2. rs6426881 in the 3'-UTR of pbx1 is involved in breast and gastric cancers via altering the binding potential of miR-522-3p.
Mohammadi M; Salehzadeh A; Talesh Sasani S; Tarang A
Mol Biol Rep; 2021 Nov; 48(11):7405-7414. PubMed ID: 34655407
[TBL] [Abstract] [Full Text] [Related]
3. HPIP protooncogene differentially regulates metabolic adaptation and cell fate in breast cancer cells under glucose stress via AMPK and RNF2 dependent pathways.
Penugurti V; Khumukcham SS; Padala C; Dwivedi A; Kamireddy KR; Mukta S; Bhopal T; Manavathi B
Cancer Lett; 2021 Oct; 518():243-255. PubMed ID: 34302919
[TBL] [Abstract] [Full Text] [Related]
4. Traditional Chinese Medicine in cancer Care: An Overview of 5834 Randomized Controlled Trials Published in Chinese.
Lu CL; Li X; Zhou HM; Zhang C; Yang YY; Feng RL; Long CJ; Deng FY; Li JC; Cao ZM; Mao QY; Zhu JP; Hong YF; Huang SY; Qiu JY; Liu YX; Wang Y; Yan YQ; Dong JM; Luo YX; Chen YM; Guan YJ; Wieland LS; Robinson N; Liu JP
Integr Cancer Ther; 2021; 20():15347354211031650. PubMed ID: 34261372
[TBL] [Abstract] [Full Text] [Related]
5. Intrafraction motion during partial breast irradiation depends on treatment time.
Hoekstra N; Habraken S; Swaak-Kragten A; Hoogeman M; Pignol JP
Radiother Oncol; 2021 Jun; 159():176-182. PubMed ID: 33798609
[TBL] [Abstract] [Full Text] [Related]
6. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
[TBL] [Abstract] [Full Text] [Related]
7. [Epidemidogical Analysis of 982 Hospitalized Cases of Childhood Acute Lymphoblastic Leukemia].
Cai YL; Zou Y; Chen XJ; Zhang L; Guo Y; Yang WY; Chen YM; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):371-376. PubMed ID: 32319365
[TBL] [Abstract] [Full Text] [Related]
8. Coexpression of pbx1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative breast cancer via Data Mining.
Qiu Y; Lu G; Wu Y
J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
[TBL] [Abstract] [Full Text] [Related]
9. Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer.
Klinkhammer-Schalke M; Steinger B; Koller M; Zeman F; Fürst A; Gumpp J; Obermaier R; Piso P; Lindberg-Scharf P;
Eur J Cancer; 2020 May; 130():102-113. PubMed ID: 32179445
[TBL] [Abstract] [Full Text] [Related]
10. Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma.
Thornton MJ; Williamson HV; Westbrook KE; Greenup RA; Plichta JK; Rosenberger LH; Gupta AM; Hyslop T; Hwang ES; Fayanju OM
Ann Surg Oncol; 2019 Oct; 26(10):3166-3177. PubMed ID: 31342392
[TBL] [Abstract] [Full Text] [Related]
11. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in breast cancer Cells.
Lappano R; Mallet C; Rizzuti B; Grande F; Galli GR; Byrne C; Broutin I; Boudieu L; Eschalier A; Jacquot Y; Maggiolini M
Cells; 2019 Jun; 8(6):. PubMed ID: 31207943
[TBL] [Abstract] [Full Text] [Related]
12. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract] [Full Text] [Related]
13. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
Vastrad B; Vastrad C; Tengli A; Iliger S
Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
[TBL] [Abstract] [Full Text] [Related]
14. PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D.
Toska E; Osmanbeyoglu HU; Castel P; Chan C; Hendrickson RC; Elkabets M; Dickler MN; Scaltriti M; Leslie CS; Armstrong SA; Baselga J
Science; 2017 Mar; 355(6331):1324-1330. PubMed ID: 28336670
[TBL] [Abstract] [Full Text] [Related]
15. Overexpression of lipid metabolism genes and pbx1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.
Wang J; Shidfar A; Ivancic D; Ranjan M; Liu L; Choi MR; Parimi V; Gursel DB; Sullivan ME; Najor MS; Abukhdeir AM; Scholtens D; Khan SA
Int J Cancer; 2017 Jun; 140(11):2484-2497. PubMed ID: 28263391
[TBL] [Abstract] [Full Text] [Related]
16. UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative breast cancer.
Gilani RA; Phadke S; Bao LW; Lachacz EJ; Dziubinski ML; Brandvold KR; Steffey ME; Kwarcinski FE; Graveel CR; Kidwell KM; Merajver SD; Soellner MB
Clin Cancer Res; 2016 Oct; 22(20):5087-5096. PubMed ID: 27154914
[TBL] [Abstract] [Full Text] [Related]
17. ChIP-BIT: Bayesian inference of target genes using a novel joint probabilistic model of ChIP-seq profiles.
Chen X; Jung JG; Shajahan-Haq AN; Clarke R; Shih IeM; Wang Y; Magnani L; Wang TL; Xuan J
Nucleic Acids Res; 2016 Apr; 44(7):e65. PubMed ID: 26704972
[TBL] [Abstract] [Full Text] [Related]
18. The pioneer factor pbx1 is a novel driver of metastatic progression in ERα-positive breast cancer.
Magnani L; Patten DK; Nguyen VT; Hong SP; Steel JH; Patel N; Lombardo Y; Faronato M; Gomes AR; Woodley L; Page K; Guttery D; Primrose L; Fernandez Garcia D; Shaw J; Viola P; Green A; Nolan C; Ellis IO; Rakha EA; Shousha S; Lam EW; Győrffy B; Lupien M; Coombes RC
Oncotarget; 2015 Sep; 6(26):21878-91. PubMed ID: 26215677
[TBL] [Abstract] [Full Text] [Related]
19. Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.
Rafiq S; Tapper W; Collins A; Khan S; Politopoulos I; Gerty S; Blomqvist C; Couch FJ; Nevanlinna H; Liu J; Eccles D
Cancer Res; 2013 Mar; 73(6):1883-91. PubMed ID: 23319801
[TBL] [Abstract] [Full Text] [Related]
20. Identification of pbx1 target genes in cancer cells by global mapping of pbx1 binding sites.
Thiaville MM; Stoeck A; Chen L; Wu RC; Magnani L; Oidtman J; Shih IeM; Lupien M; Wang TL
PLoS One; 2012; 7(5):e36054. PubMed ID: 22567123
[TBL] [Abstract] [Full Text] [Related]
[Next]
